Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
Boston Scientific’s post‑cyberattack outlook signals a potential miss on its 2026 sales and profit targets.
5 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 5 separate news trends connected to Boston Scientific, spanning August 26, 2026 through September 8, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 36 article observations and 35 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Boston Scientific’s post‑cyberattack outlook signals a potential miss on its 2026 sales and profit targets.
Boston Scientific’s cyberattack forces a surprise miss of its 2026 earnings guidance, rattling investors and spotlighting security risks.
Boston Scientific removes angiographic and imaging catheters from the market following high-severity device recalls and safety alerts.
Boston Scientific's cyberattack has halted global operations, raising concerns about medical device availability.
Boston Scientific's global operations are disrupted by a cyberattack, sending shares down